Congenital Chagas' disease: diagnostic and clinical aspects

Clin Infect Dis. 1995 Sep;21(3):551-5. doi: 10.1093/clinids/21.3.551.

Abstract

The diagnostic and clinical aspects of congenital Chagas' disease were studied in 71 children in Buenos Aires. The children's ages ranged from 2 days to 10 years. In infants < 6 months old, the disease was diagnosed by detection of Trypanosoma cruzi in the blood; the microhematocrit test was positive in 38 (97.4%) of 39 cases. This test was the fastest and most reliable diagnostic method in this group, whereas two conventional serological methods were useful in children > or = 6 months of age. Forty-six (64.8%) of the 71 children had no clinical signs of infection. The clinical sign most frequently documented was hepatomegaly (18.3%). Three children were coinfected with human immunodeficiency virus; the latter infection was severe in two instances. Nifurtimox (10-15 mg/[kg.d] for 2 months) was used for parasiticidal treatment, and use of this drug resulted in mild adverse effects.

MeSH terms

  • Animals
  • Antibodies, Protozoan / blood
  • Argentina
  • Chagas Disease / congenital*
  • Chagas Disease / diagnosis
  • Chagas Disease / drug therapy
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Male
  • Nifurtimox / adverse effects
  • Nifurtimox / therapeutic use
  • Parasitemia / diagnosis
  • Pregnancy
  • Serologic Tests
  • Trypanocidal Agents / adverse effects
  • Trypanocidal Agents / therapeutic use
  • Trypanosoma cruzi / immunology
  • Trypanosoma cruzi / isolation & purification

Substances

  • Antibodies, Protozoan
  • Trypanocidal Agents
  • Nifurtimox